adplus-dvertising

Study Shows How Key Protein Drives Our Immune Response Against Viruses

Their findings, which provide a target for new therapies that could improve anti-viral responses in some patients and reduce autoimmune problems in others when immune responses run out of control, have just been published in leading journal

Interferons and MDNA – a major piece of the puzzle

“Interferons” are key proteins that tell our immune systems when viruses, germs or cancer cells are in our bodies. Type I interferons are produced when the innate immune system senses the presence of a virus. In such circumstances interferons trigger a complex chain of events in which other cells are kicked into gear to “interfere with” and fight those invaders.

Scientists don’t fully understand how certain links in that chain of events are controlled—making it difficult to stimulate or suppress an immune response with therapeutic interventions—but this new research has provided key new insights into the process.

Their work shows that MDNA regulates a transcription factor, IRF7, which in essence drives Type I interferon production.

Professor Andrew Bowie said:

“We have been interested in better understanding how Type I interferons are produced from blood cells because they are required to fight viruses, and because too much of them—when the production process runs out of control, for example—contributes to nasty autoimmune diseases such as interferonopathies.

“There is a family of proteins called PYHIN proteins which we have been working on for some time, as they are implicated in regulating innate immunity. To our surprise, one such PYHIN protein, called MNDA, turned out to be a big missing piece in the puzzle in understanding how type I interferon production is sustained, which makes this discovery all the more exciting.

“If we can learn how to manipulate MNDA’s activity it could be really beneficial – on one hand to boost an interferon response during a viral infection, for example upon COVID-19 infection, or on the other hand to supress interferon production and treat an autoimmune disorder.”

The scientists are currently examining how MNDA contributes to innate immune responses to COVID-19.

This work was funded by the Irish Higher Education Authority (HEA), grants from Science Foundation Ireland, the National Institutes of Health, and by a Bio-technology and Biological Sciences Research Council-Science Foundation Ireland joint award.

Source: Eurekalert

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.